Lyell Immunopharma, Inc. SEC filings LYEL
Lyell Immunopharma, Inc. has 359 filings in SEC EDGAR's recent list, going back to Mar 20, 2020. Its latest annual report, Form ARS, was filed on Apr 24, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 5, 2026 | Nov 4, 2026 |
| 4 | Insider transaction | Nov 5, 2026 | Nov 4, 2026 |
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| 8-K |
Current report
Unregistered share sale
|
Nov 4, 2026 | Nov 3, 2026 |
| 4 | Insider transaction | Oct 13, 2026 | Oct 12, 2026 |
| 4 | Insider transaction | Sep 10, 2026 | Sep 10, 2026 |
| 4 | Insider transaction | Sep 10, 2026 | Sep 10, 2026 |
| 3 | Initial insider ownership | Sep 10, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Other events
|
Sep 10, 2026 | Sep 10, 2026 |
| 4 | Insider transaction | Aug 25, 2026 | Aug 21, 2026 |
| 4 | Insider transaction | Aug 25, 2026 | Aug 21, 2026 |
| 4 | Insider transaction | Aug 25, 2026 | Aug 21, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Aug 14, 2026 | — |
| 4 | Insider transaction | Aug 11, 2026 | Aug 10, 2026 |
| 4 | Insider transaction | Aug 11, 2026 | Aug 10, 2026 |
| 4 | Insider transaction | Aug 11, 2026 | Aug 10, 2026 |
| 4 | Insider transaction | Aug 11, 2026 | Aug 10, 2026 |
| 10-Q | Quarterly report | Aug 6, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 6, 2026 | Aug 6, 2026 |
| 4 | Insider transaction | Jul 27, 2026 | Jul 27, 2026 |
| 4 | Insider transaction | Jul 27, 2026 | Jul 27, 2026 |
| EFFECT | Filing | Jul 21, 2026 | — |
| 4 | Insider transaction | Jul 20, 2026 | Jul 17, 2026 |
| 4 | Insider transaction | Jul 17, 2026 | Jul 16, 2026 |
| CORRESP | Letter to the SEC | Jul 17, 2026 | — |
| UPLOAD | Letter from the SEC | Jul 16, 2026 | — |
| S-3 | Shelf registration | Jul 13, 2026 | — |
| 4 | Insider transaction | Jul 1, 2026 | Jun 29, 2026 |
| 4 | Insider transaction | Jun 18, 2026 | Jun 15, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jun 18, 2026 | — |
| 3 | Initial insider ownership | Jun 18, 2026 | May 18, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | May 11, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | May 11, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | May 11, 2026 |
| 4 | Insider transaction | Jun 15, 2026 | May 11, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 15, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2025 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 12, 2026 | Jun 10, 2026 |
| 4 | Insider transaction | Jun 11, 2026 | Jun 10, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 11, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 8, 2026 | — |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 6, 2026 | May 6, 2026 |
| ARS | Annual report to shareholders | Apr 24, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 24, 2026 | — |
| DEF 14A | Proxy statement | Apr 24, 2026 | Jun 10, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 21, 2026 | — |
| EFFECT | Filing | Apr 14, 2026 | — |
| CORRESP | Letter to the SEC | Apr 13, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 8, 2026 | — |
| S-3 | Shelf registration | Apr 3, 2026 | — |
| 4 | Insider transaction | Mar 16, 2026 | Mar 9, 2026 |
| 3 | Initial insider ownership | Mar 16, 2026 | Mar 9, 2026 |
| S-8 | Employee stock plan registration | Mar 12, 2026 | — |
| 10-K | Annual report | Mar 12, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 12, 2026 | Mar 12, 2026 |
| 4 | Insider transaction | Mar 9, 2026 | Mar 6, 2026 |
| 4 | Insider transaction | Mar 9, 2026 | Mar 6, 2026 |
| 8-K |
Current report
Officer or director change
|
Mar 9, 2026 | Mar 6, 2026 |
| 4 | Insider transaction | Feb 12, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 12, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 12, 2026 | Feb 11, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 10, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 10, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 10, 2026 |
| 4 | Insider transaction | Jan 6, 2026 | Dec 24, 2025 |
| 424B5 | Prospectus supplement | Dec 18, 2025 | — |
| EFFECT | Filing | Dec 15, 2025 | — |
| CORRESP | Letter to the SEC | Dec 11, 2025 | — |
| 8-K |
Current report
Other events
|
Dec 8, 2025 | Dec 7, 2025 |
| S-3 | Shelf registration | Dec 5, 2025 | — |
| 8-K |
Current report
Bylaw or fiscal year change
|
Dec 5, 2025 | Dec 3, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 14, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Nov 13, 2025 | — |
| 4 | Insider transaction | Nov 12, 2025 | Nov 10, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 10, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 10, 2025 |
| 4 | Insider transaction | Nov 12, 2025 | Nov 10, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Nov 12, 2025 | — |
| 10-Q | Quarterly report | Nov 12, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 3 | Initial insider ownership | Nov 10, 2025 | Oct 31, 2025 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Nov 10, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Officer or director change
|
Nov 3, 2025 | Oct 31, 2025 |
| 4 | Insider transaction | Oct 29, 2025 | Oct 27, 2025 |
| 4 | Insider transaction | Oct 29, 2025 | Oct 27, 2025 |
| 4 | Insider transaction | Oct 29, 2025 | Oct 27, 2025 |
| 8-K |
Current report
Officer or director change
|
Sep 16, 2025 | Sep 15, 2025 |
| 4 | Insider transaction | Aug 22, 2025 | Aug 20, 2025 |
| 4 | Insider transaction | Aug 22, 2025 | Aug 20, 2025 |
| 4 | Insider transaction | Aug 22, 2025 | Aug 20, 2025 |
| 4 | Insider transaction | Aug 22, 2025 | Aug 20, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 19, 2025 | — |
| EFFECT | Filing | Aug 15, 2025 | — |
| 4 | Insider transaction | Aug 13, 2025 | Aug 11, 2025 |
| 4 | Insider transaction | Aug 13, 2025 | Aug 11, 2025 |
| 4 | Insider transaction | Aug 13, 2025 | Aug 11, 2025 |
| 4 | Insider transaction | Aug 13, 2025 | Aug 11, 2025 |
| CORRESP | Letter to the SEC | Aug 13, 2025 | — |
| UPLOAD | Letter from the SEC | Aug 13, 2025 | — |
| S-3 | Shelf registration | Aug 12, 2025 | — |
| 10-Q | Quarterly report | Aug 12, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 1, 2025 | — |
| 424B5 | Prospectus supplement | Jul 31, 2025 | — |
| EFFECT | Filing | Jul 30, 2025 | — |
| 4 | Insider transaction | Jul 29, 2025 | Jul 25, 2025 |
| 3 | Initial insider ownership | Jul 29, 2025 | Jul 25, 2025 |
| CORRESP | Letter to the SEC | Jul 28, 2025 | — |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure
|
Jul 25, 2025 | Jul 24, 2025 |
| UPLOAD | Letter from the SEC | Jul 23, 2025 | — |
| S-3 | Shelf registration | Jul 18, 2025 | — |
| 8-K |
Current report
Unregistered share sale
|
Jun 26, 2025 | Jun 20, 2025 |
| 8-K |
Current report
Other events
|
Jun 17, 2025 | Jun 17, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 11, 2025 | Jun 9, 2025 |
| 3 | Initial insider ownership | Jun 11, 2025 | Jun 9, 2025 |
| 3 | Initial insider ownership | Jun 11, 2025 | Jun 9, 2025 |
| 3 | Initial insider ownership | Jun 11, 2025 | Jun 9, 2025 |
| 8-K |
Current report
Officer or director change
|
Jun 9, 2025 | Jun 9, 2025 |
| 8-K |
Current report
Change to shareholder rights
|
May 28, 2025 | May 27, 2025 |
| 8-K |
Current report
Shareholder vote results
|
May 21, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 15, 2025 |
| 4 | Insider transaction | May 19, 2025 | May 15, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | May 15, 2025 | — |
| 10-Q | Quarterly report | May 13, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations
|
May 13, 2025 | May 13, 2025 |
| ARS | Annual report to shareholders | Apr 21, 2025 | Dec 31, 2024 |
| DEF 14A | Proxy statement | Apr 21, 2025 | May 15, 2025 |
| PRE 14A | Preliminary proxy statement | Apr 10, 2025 | May 15, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Exit or restructuring costs, Officer or director change, Regulation FD disclosure
|
Apr 1, 2025 | Mar 27, 2025 |
| 4 | Insider transaction | Mar 25, 2025 | Mar 21, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 17, 2025 |
| 4 | Insider transaction | Mar 18, 2025 | Mar 14, 2025 |
| S-8 | Employee stock plan registration | Mar 11, 2025 | — |
| 10-K | Annual report | Mar 11, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 11, 2025 | Mar 11, 2025 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 10, 2025 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 10, 2025 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 10, 2025 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 10, 2025 |
| 4 | Insider transaction | Feb 26, 2025 | Feb 10, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 14, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 5, 2025 | — |
| 8-K |
Current report
Listing notice
|
Jan 24, 2025 | Jan 23, 2025 |
| 8-K/A | Amended current report | Jan 10, 2025 | Oct 31, 2024 |
| 8-K |
Current report
Other events
|
Dec 10, 2024 | Dec 9, 2024 |
| 424B5 | Prospectus supplement | Dec 9, 2024 | — |
| EFFECT | Filing | Dec 5, 2024 | — |
| CORRESP | Letter to the SEC | Dec 3, 2024 | — |
| UPLOAD | Letter from the SEC | Dec 3, 2024 | — |
| S-3 | Shelf registration | Nov 29, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Nov 26, 2024 | Nov 22, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 4, 2024 | — |
| 4 | Insider transaction | Nov 1, 2024 | Oct 31, 2024 |
| 3 | Initial insider ownership | Nov 1, 2024 | Oct 31, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 31, 2024 | — |
| 8-K |
Current report
Material agreement, Acquisition or sale of assets, Officer or director change, Regulation FD disclosure
|
Oct 31, 2024 | Oct 31, 2024 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Oct 24, 2024 | Oct 24, 2024 |
| 10-Q | Quarterly report | Aug 7, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 7, 2024 | Aug 7, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 26, 2024 | Jun 26, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 14, 2024 |
| 4 | Insider transaction | Jun 17, 2024 | Jun 14, 2024 |
| 8-K |
Current report
Shareholder vote results
|
Jun 14, 2024 | Jun 14, 2024 |
| 424B5 | Prospectus supplement | May 6, 2024 | — |
| 10-Q | Quarterly report | May 6, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 6, 2024 | May 6, 2024 |
| EFFECT | Filing | May 3, 2024 | — |
| CORRESP | Letter to the SEC | May 1, 2024 | — |
| ARS | Annual report to shareholders | Apr 22, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 22, 2024 | — |
| DEF 14A | Proxy statement | Apr 22, 2024 | Jun 14, 2023 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- LYEL (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- South San Francisco, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1806952
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.